239 related articles for article (PubMed ID: 9076581)
1. An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats.
Armamento-Villareal R; Ziambaras K; Abbasi-Jarhomi SH; Dimarogonas A; Halstead L; Fausto A; Avioli LV; Civitelli R
J Bone Miner Res; 1997 Mar; 12(3):384-92. PubMed ID: 9076581
[TBL] [Abstract][Full Text] [Related]
2. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
3. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
[TBL] [Abstract][Full Text] [Related]
4. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
[TBL] [Abstract][Full Text] [Related]
5. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
[TBL] [Abstract][Full Text] [Related]
6. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
Zhou H; Shen V; Dempster DW; Lindsay R
J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
[TBL] [Abstract][Full Text] [Related]
7. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
Rhee Y; Won YY; Baek MH; Lim SK
J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
[TBL] [Abstract][Full Text] [Related]
8. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
[TBL] [Abstract][Full Text] [Related]
9. Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats.
Liu CC; Kalu DN
J Bone Miner Res; 1990 Sep; 5(9):973-82. PubMed ID: 2281827
[TBL] [Abstract][Full Text] [Related]
10. Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats.
Shen V; Birchman R; Liang XG; Wu DD; Dempster DW; Lindsay R
J Bone Miner Res; 1998 May; 13(5):883-90. PubMed ID: 9610753
[TBL] [Abstract][Full Text] [Related]
11. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
[TBL] [Abstract][Full Text] [Related]
12. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
13. Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats.
Takano Y; Tanizawa T; Mashiba T; Endo N; Nishida S; Takahashi HE
J Bone Miner Res; 1996 Feb; 11(2):169-77. PubMed ID: 8822340
[TBL] [Abstract][Full Text] [Related]
14. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
Lane NE; Thompson JM; Strewler GJ; Kinney JH
J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
[TBL] [Abstract][Full Text] [Related]
15. Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine.
Fox J; Miller MA; Newman MK; Turner CH; Recker RR; Smith SY
J Bone Miner Res; 2007 Feb; 22(2):260-73. PubMed ID: 17087625
[TBL] [Abstract][Full Text] [Related]
16. Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis.
Ibbotson KJ; Orcutt CM; D'Souza SM; Paddock CL; Arthur JA; Jankowsky ML; Boyce RW
J Bone Miner Res; 1992 Apr; 7(4):425-32. PubMed ID: 1609630
[TBL] [Abstract][Full Text] [Related]
17. Effect of intermittent administration of human parathyroid hormone on bone mineral density and arthritis in rats with collagen-induced arthritis.
Fukata S; Hagino H; Okano T; Yamane I; Kameyama Y; Teshima R
Arthritis Rheum; 2004 Dec; 50(12):4060-9. PubMed ID: 15593226
[TBL] [Abstract][Full Text] [Related]
18. SOST is a target gene for PTH in bone.
Keller H; Kneissel M
Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase.
Rixon RH; Whitfield JF; Gagnon L; Isaacs RJ; Maclean S; Chakravarthy B; Durkin JP; Neugebauer W; Ross V; Sung W
J Bone Miner Res; 1994 Aug; 9(8):1179-89. PubMed ID: 7976500
[TBL] [Abstract][Full Text] [Related]
20. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone.
Hock JM; Gera I
J Bone Miner Res; 1992 Jan; 7(1):65-72. PubMed ID: 1532281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
